Literature DB >> 25333243

A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.

Yasemin Yaz, Nazmiye Erol, Huseyin Gursoy, Hikmet Basmak, Mustafa D Bilgec.   

Abstract

A second anterior ridge formed 8 weeks after therapy in a case of zone II, stage 3 retinopathy of prematurity, which was treated with intravitreal bevacizumab injection alone. The clinical appearance was defined as "double ridge." Retinopathy of prematurity cases treated only with intravitreal bevacizumab injections may progress; therefore, close follow-up is recommended. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25333243     DOI： 10.3928/01913913-20140930-01

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN： 0191-3913            Impact factor:   1.402


  3 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Smouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy.

Authors:  Divya Balakrishnan; Vikas Ambiya; Subhadra Jalali; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2016-08-29

Review 3.  A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.

Authors:  Laura Pertl; Gernot Steinwender; Christoph Mayer; Silke Hausberger; Eva-Maria Pöschl; Werner Wackernagel; Andreas Wedrich; Yosuf El-Shabrawi; Anton Haas
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.